Gennex Laboratories Limited (GENNEX.BO)
INR 17.5
(-0.74%)
INR 17.5
(-0.74%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 57.2 Million INR | 442.95% |
| 2022 | 10.53 Million INR | -89.59% |
| 2021 | 101.23 Million INR | 37.51% |
| 2020 | 73.61 Million INR | 47.7% |
| 2019 | 49.84 Million INR | 9.82% |
| 2018 | 45.38 Million INR | 83.74% |
| 2017 | 24.7 Million INR | -35.62% |
| 2016 | 38.37 Million INR | 69.15% |
| 2015 | 22.68 Million INR | -37.23% |
| 2014 | 36.13 Million INR | 23.93% |
| 2013 | 29.16 Million INR | 37.91% |
| 2012 | 21.14 Million INR | 34.76% |
| 2011 | 15.69 Million INR | 1.05% |
| 2010 | 15.52 Million INR | -17.24% |
| 2009 | 18.76 Million INR | 20.09% |
| 2008 | 15.62 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 57.2 Million INR | 442.95% |
| 2023 Q4 | 57.2 Million INR | 0.0% |
| 2023 Q2 | 218.65 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 10.53 Million INR | -89.59% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 37.11 Million INR | 0.0% |
| 2022 Q4 | 10.53 Million INR | 0.0% |
| 2021 Q2 | 80.04 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 101.23 Million INR | 37.51% |
| 2021 Q4 | 101.23 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 73.61 Million INR | 47.7% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 73.61 Million INR | 0.0% |
| 2020 Q2 | 64.82 Million INR | 0.0% |
| 2019 Q4 | 49.84 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 44.9 Million INR | 0.0% |
| 2019 FY | 49.84 Million INR | 9.82% |
| 2018 Q2 | 19.57 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 45.38 Million INR | 83.74% |
| 2018 Q4 | 45.38 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q4 | 24.7 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 22.12 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 24.7 Million INR | -35.62% |
| 2016 FY | 38.37 Million INR | 69.15% |
| 2016 Q2 | 26.8 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 39.96 Million INR | 0.0% |
| 2015 FY | 22.68 Million INR | -37.23% |
| 2015 Q4 | 22.68 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 37.31 Million INR | 0.0% |
| 2014 Q2 | 38.69 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 36.13 Million INR | 23.93% |
| 2014 Q4 | 36.13 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 22.24 Million INR | 0.0% |
| 2013 Q4 | 29.16 Million INR | 0.0% |
| 2013 FY | 29.16 Million INR | 37.91% |
| 2012 Q4 | 21.14 Million INR | 0.0% |
| 2012 FY | 21.14 Million INR | 34.76% |
| 2011 FY | 15.69 Million INR | 1.05% |
| 2011 Q4 | 19.18 Million INR | 0.0% |
| 2010 Q4 | 15.52 Million INR | 0.0% |
| 2010 FY | 15.52 Million INR | -17.24% |
| 2009 FY | 18.76 Million INR | 20.09% |
| 2008 Q4 | 15.62 Million INR | 0.0% |
| 2008 FY | 15.62 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.56 Million INR | -123.776% |
| KIMIA BIOSCIENCES LIMITED | 437.07 Million INR | 86.912% |
| SHELTER PHARMA LIMITED | 5.77 Million INR | -890.906% |
| Vasundhara Rasayans Limited | 19.46 Million INR | -193.886% |
| Sunil Healthcare Limited | 661.51 Million INR | 91.352% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 10.09 Billion INR | 99.433% |
| Bharat Immunologicals & Biologicals Corporation Limited | 702.24 Million INR | 91.854% |
| Patidar Buildcon Limited | 25.32 Million INR | -125.901% |
| Roopa Industries Limited | 258.54 Million INR | 77.874% |
| Smruthi Organics Limited | 117.03 Million INR | 51.121% |
| Trident Lifeline Limited | 184.1 Million INR | 68.928% |
| PANJON LTD. | 14.36 Million INR | -298.114% |
| Pharmaids Pharmaceuticals Limited | 85.32 Million INR | 32.959% |
| Gujarat Terce Laboratories Limited | 38.66 Million INR | -47.95% |
| TIAAN CONSUMER LIMITED | 14.8 Million INR | -286.52% |
| Anuh Pharma Limited | 26.92 Million INR | -112.437% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 1.09 Million INR | -5128.976% |
| Sandu Pharmaceuticals Limited | 633 Thousand INR | -8937.125% |
| Tyche Industries Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 1.05 Billion INR | 94.578% |
| Trimurthi Limited | - INR | -Infinity% |
| Shukra Pharmaceuticals Limited | 31.53 Million INR | -81.379% |
| Norris Medicines Limited | 215.23 Million INR | 73.422% |
| Zenlabs Ethica Limited | 148.59 Million INR | 61.503% |
| Vikram Thermo (India) Limited | 70.43 Million INR | 18.786% |
| ANG Lifesciences India Limited | 728.36 Million INR | 92.146% |
| Parmax Pharma Limited | 53.72 Million INR | -6.482% |
| Veerhealth Care Limited | - INR | -Infinity% |
| Deccan Health Care Limited | 18.95 Million INR | -201.857% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 94.543% |
| Makers Laboratories Limited | 194.92 Million INR | 70.652% |
| Lactose (India) Limited | 392.52 Million INR | 85.426% |
| OXYGENTA PHARMACEUTICAL LIMITE | 572.33 Million INR | 90.005% |
| Zenith Healthcare Limited | - INR | -Infinity% |
| Sanjivani Paranteral Limited. | 9.69 Million INR | -490.29% |
| Bacil Pharma Limited | 984 Thousand INR | -5713.516% |
| PRAVEG LIMITED | 596.11 Million INR | 90.404% |
| Denis Chem Lab Limited | 10.46 Million INR | -446.893% |
| Kwality Pharmaceuticals Limited | 981.19 Million INR | 94.17% |
| Jenburkt Pharmaceuticals Limited | - INR | -Infinity% |
| Colinz Laboratories Limited | 5.69 Million INR | -903.949% |
| Godavari Drugs Limited | 556.24 Million INR | 89.716% |
| SHAMROCK INDUSTRIAL CO.LTD. | - INR | -Infinity% |
| Zenotech Laboratories Limited | - INR | -Infinity% |
| Panchsheel Organics Limited | 63.09 Million INR | 9.329% |
| Shree Ganesh Remedies Limited | 364.49 Million INR | 84.306% |
| Vivanza Biosciences Limited | 51.69 Million INR | -10.659% |
| Phaarmasia Limited | 1.44 Million INR | -3869.813% |
| Sastasundar Ventures Limited | 38.82 Million INR | -47.329% |
| Medi-Caps Limited | - INR | -Infinity% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 27.68 Million INR | -106.636% |
| Ambalal Sarabhai Enterprises Limited | 461.12 Million INR | 87.594% |
| Mercury Laboratories Limited | 55.53 Million INR | -3.005% |
| BDH Industries Limited | 86.9 Million INR | 34.177% |
| Coral Laboratories Limited | - INR | -Infinity% |
| Concord Drugs Limited | 165.94 Million INR | 65.527% |
| Bharat Parenterals Limited | 1.57 Billion INR | 96.37% |
| Beryl Drugs Limited | 50.93 Million INR | -12.301% |
| Vista Pharmaceuticals Limited | 79.64 Million INR | 28.178% |
| Evoq Remedies Limited | 42.38 Million INR | -34.975% |
| Add-Shop E-Retail Limited | 127.73 Million INR | 55.217% |
| Transchem Limited | - INR | -Infinity% |
| Ishita Drugs and Industries Limited | - INR | -Infinity% |
| Parnax Lab Limited | 806.38 Million INR | 92.906% |
| Source Natural Foods and Herbal Supplements Limited | 35 Thousand INR | -163342.857% |
| Kerala Ayurveda Limited | 675.77 Million INR | 91.535% |
| Cian Healthcare Limited | 556.91 Million INR | 89.728% |
| Trinity League India Limited | 242 Thousand INR | -23538.43% |
| Syschem (India) Limited | 4.5 Million INR | -1171.222% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 95.905% |
| Natural Capsules Limited | 1.09 Billion INR | 94.752% |
| Auro Laboratories Limited | 262.43 Million INR | 78.202% |